ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0794

Microbiota-dependent Indole Production Is Required for the Development of Collagen-induced Arthritis

Brenda Seymour1, Brandon Trent2, Brendan Allen3, Sucai Liu3, Sunny Sneed4, Robert Anthony4 and kristine Kuhn3, 1University of Colorado School of Medicine, Denver, CO, 2University of Colorado School of Medicine, Eugene, OR, 3University of Colorado School of Medicine, Aurora, CO, 4Harvard Medical School, Boston, MA

Meeting: ACR Convergence 2023

Keywords: Animal Model, metabolomics, microbiome, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 12, 2023

Title: Abstracts: RA – Animal Models

Session Type: Abstract Session

Session Time: 4:00PM-5:30PM

Background/Purpose: While alterations in tryptophan (Trp) metabolism have been broadly implicated across autoimmune diseases (including RA, SpA, SLE, and MS), the specific role(s) of Trp metabolites in the development of disease are not well characterized. We previously identified significant alterations in tryptophan metabolism in mice with collagen-induced arthritis (CIA) that occurred in a microbiome-dependent manner, including significantly elevated indole. As indole is exclusively produced via microbial Trp metabolism, we modulated indole production through either antibiotic-mediated microbiome depletion or reduction of dietary Trp to dissect the effects of tryptophan, indole, and the microbiome on the development of CIA.

Methods: To regulate dietary Trp, 6wk-old male DBA/1J mice were maintained on either a Trp-sufficient (TS, 0.18% Trp) or Trp-low (TL, 0.05% Trp) diet. For the microbiome depletion studies, mice were treated with broad-spectrum antibiotics (ampicillin, neomycin, metronidazole, and vancomycin) in the setting of a Trp-sufficient diet. CIA was induced by immunization of bovine type II collagen (CII) emulsified in CFA at days 0 and 21. Indole or vehicle were added back either in drinking water or by oral gavage. CIA severity was assessed clinically and histologically. On day 35, serum and tissues were analyzed by flow cytometry, ELISA, and immunohistochemistry.

Results: Depletion of either the microbiome or dietary Trp protected mice from developing CIA. Adding back indole in either setting rescued CIA severity, suggesting that indole is sufficient to incite disease. These findings were confirmed further by amelioration of disease in mice colonized with tryptophanase-deficient bacteria, which are unable to produce indole. Indole supplementation in the TL setting lead to significant increases in RA-relevant serum cytokines (IL-6, TNF, IL-1β) and IL-17-producing, CII-reactive Th17 cells. Indole supplementation also resulted in increased activation of complement by CII-specific antibodies, C3 deposition in the joints, CII-specific IgG2b, and antibody galactosylation compared to the Trp-sufficient group.

Conclusion: Altogether, our data suggest that the presence of either the microbiota or dietary Trp alone are insufficient to induce disease, and that microbial metabolism of Trp into indole is essential for CIA development. Indole supplementation induces a pro-inflammatory, Th17-skewed immune signature. As IgG2b and galactosylation are thought to promote complement binding and activation, our findings suggest that indole supplementation may enhance pathogenic autoantibody function, which is consistent with the observed increase in complement activation and C3 deposition in the joints. While the cellular target(s) of indole are yet to be identified, this data provides a novel mechanism through which altered tryptophan metabolism promotes disease development in the CIA model. Furthermore, these findings identify microbiome-mediated modulation of Trp metabolism as a potential pathway to block or treat disease.


Disclosures: B. Seymour: None; B. Trent: None; B. Allen: None; S. Liu: None; S. Sneed: None; R. Anthony: None; k. Kuhn: pfizer, 5, ucb, 2.

To cite this abstract in AMA style:

Seymour B, Trent B, Allen B, Liu S, Sneed S, Anthony R, Kuhn k. Microbiota-dependent Indole Production Is Required for the Development of Collagen-induced Arthritis [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/microbiota-dependent-indole-production-is-required-for-the-development-of-collagen-induced-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/microbiota-dependent-indole-production-is-required-for-the-development-of-collagen-induced-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology